These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques. Wu KK; Hoak JC; Koepke JA; Thompson JS Transfusion; 1977; 17(6):638-43. PubMed ID: 145673 [TBL] [Abstract][Full Text] [Related]
8. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection. Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444 [TBL] [Abstract][Full Text] [Related]
9. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients. Menitove JE; Duquesnoy RJ Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758 [TBL] [Abstract][Full Text] [Related]
10. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients. Friedberg RC; Donnelly SF; Mintz PD Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893 [TBL] [Abstract][Full Text] [Related]
11. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion. Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. McFarland JG; Anderson AJ; Slichter SJ Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125 [TBL] [Abstract][Full Text] [Related]
13. HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening. Kreuger AL; Mäkelburg ABU; Somers JAE; Tomson B; van de Watering LMG; van der Bom JG; van Kraaij MGJ; Weller CM Transfusion; 2019 Nov; 59(11):3303-3307. PubMed ID: 31602653 [TBL] [Abstract][Full Text] [Related]
14. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets]. Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437 [TBL] [Abstract][Full Text] [Related]
15. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Schiffer CA; O'Connell B; Lee EJ Blood; 1989 Aug; 74(3):1172-6. PubMed ID: 2752158 [TBL] [Abstract][Full Text] [Related]
16. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [TBL] [Abstract][Full Text] [Related]
17. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience. Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964 [TBL] [Abstract][Full Text] [Related]
18. The alloimmunized patient: effective transfusion support and newer experimental approaches. Pamphilon DH Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334 [TBL] [Abstract][Full Text] [Related]
19. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
20. Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates. O'Connell BA; Schiffer CA Transfusion; 1990 May; 30(4):314-7. PubMed ID: 2349631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]